Citation Impact
Citing Papers
H 2 S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase
2008 StandoutScience
A microRNA expression signature of human solid tumors defines cancer gene targets
2006 Standout
A bacterium that degrades and assimilates poly(ethylene terephthalate)
2016 StandoutScience
The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma
2006
Genome-wide gain-of-function screen identifies novel regulators of pluripotency
2010
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
2007
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
2001
Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss
2000
SAGE analysis of neuroblastoma reveals a high expression of the human homologue of theDrosophila Delta gene
2000
Disruption of Cooperation Between Ras and MycN in Human Neuroblastoma Cells Promotes Growth Arrest
2005
The Third Intergroup Rhabdomyosarcoma Study.
1995 Standout
Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma
1999
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
2000 StandoutNobel
Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study
1997
Homozygous deletion in a neuroblastoma cell line defined by a high‐density STS map spanning human chromosome band 1p36
2001
Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
1998
Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee.
1990
Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma
2005
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Detailed molecular analysis of 1p36 in neuroblastoma
2001
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
2009
A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response
2009
Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low‐dose etoposide on intergroup rhabdomyosarcoma study III: An interim report
1994
c-Myc-regulated microRNAs modulate E2F1 expression
2005 StandoutNature
Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors
2002
Cancer Metastasis: Building a Framework
2006 Standout
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
2006 StandoutNobel
Origins and Mechanisms of miRNAs and siRNAs
2009 Standout
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Lonely No More: p53 Finds Its Kin in a Tumor Suppressor Haven
1997
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature
2003
COMPARATIVE GENOMIC HYBRIDIZATION (CGH) ANALYSIS OF NEUROBLASTOMAS—AN IMPORTANT METHODOLOGICAL APPROACH IN PAEDIATRIC TUMOUR PATHOLOGY
1997
Differential expression in SAGE: accounting for normal between-library variation
2003
The Epigenomics of Cancer
2007 Standout
Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes
1997
Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band
2006
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
1999
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
1997
Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers
1997
Disomy 1 with terminal 1 p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants
1999
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?
2001
Characterization of Nucleophosmin (B23) as a Myc Target by Scanning Chromatin Immunoprecipitation
2001
Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network
2003
Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations
2002
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Children's Oncology Group's 2013 blueprint for research: Bone tumors
2012
Chemotherapy for Osteosarcoma without High-Dose Methotrexate: A 12-Year Follow-Up on 53 Patients
2007
The c-Myc target gene network
2006
Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization
1998
Incidence of second primary tumours among childhood cancer survivors
1987
Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues
1995
Tumor size and prognosis in aggressively treated osteosarcoma.
1996
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
1999 StandoutNatureNobel
Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted
2000
Role of Ploidy, Chromosome 1p, and Schwann Cells in the Maturation of Neuroblastoma
1996
Common Solid Tumors of Childhood
1991
Overexpression of the wild type p73 gene in human bladder cancer
1999
Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project
2006
Malignant Gliomas in Adults
2008 Standout
Genetic epidemiology of neuroblastoma: A study of 426 cases at the Institut Gustave‐Roussy in France
2003
MicroRNA-10a Binds the 5′UTR of Ribosomal Protein mRNAs and Enhances Their Translation
2008
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Limb salvage in musculoskeletal oncology
2003
Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute
2001
p73 is a human p53-related protein that can induce apoptosis
1997 StandoutNatureNobel
Comprehensive analysis of chromosome 1p deletions in neuroblastoma
2001
MicroRNAs and Cancer: Short RNAs Go a Long Way
2009
PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic β Cells
2008 StandoutNobel
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Osteosarcoma of the limbs.Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation
1988
Neuroblastoma
2007 Standout
Smallest region of overlapping deletion in 1p36 in human neuroblastoma: A 1 Mbp cosmid and PAC contig
2001
Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma
1995
Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)
2003
p63 is a p53 homologue required for limb and epidermal morphogenesis
1999 StandoutNature
Delaying surgery with chemotherapy for osteosarcoma of the extremities
2004
Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform
2005
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2
2002
Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee.
1993
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
1999 StandoutNature
Variety and complexity of chromosome 17 translocations in neuroblastoma
2003
Transcriptional regulation and transformation by Myc proteins
2005
Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis
1996
Molecular genetic analysis of familial neuroblastoma
1997
Mechanism and relevance of ploidy in neuroblastoma
2000
p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities
1998 Standout
A microRNA polycistron as a potential human oncogene
2005 StandoutNature
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Prognostic significance of DNA di-tetraploidy in neuroblastoma
2001
Genetic parameters of neuroblastomas
2002
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
2000 StandoutNatureNobel
Metaiodobenzylguanidine assessment of metastatic neuroblastoma: Observer dependency and chemosensitivity evaluation
2000
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma
2004
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
2005
Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup
2007
Natural History and Biology of Stage A Neuroblastoma: A Pediatric Oncology Group Study
2000
131I MIBG therapy in neuroblastoma: Mechanisms, rationale, and current status
1999
On the shoulders of giants: p63, p73 and the rise of p53
2002
Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
1989
Tumor response and toxicity with multiple infusions of high dose 131I‐MIBG for refractory neuroblastoma
2004
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas
2000
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
1998
Biology and Genetics of Human Neuroblastomas
1997
Late effects of childhood cancer therapy
2002
Common Musculoskeletal Tumors of Childhood and Adolescence
1999
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
2013 Standout
Quantitative proteomic analysis of Myc oncoprotein function
2002
Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.
2000
PPM1D is a potential target for 17q gain in neuroblastoma.
2003
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group
2003
Rhodopsin Kinase Activity in the Mammalian Pineal Gland and Other Tissues
1984 Science
Association of CYP 3 A 4 genotype with treatment-related leukemia
1998
The International Neuroblastoma Pathology Classification (the Shimada system)
1999
Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.
1998
The Protein Kinase Complement of the Human Genome
2002 StandoutScience
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Mass spectrometry-based proteomics
2003 StandoutNature
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
2003
Hematologic Toxicity of High-Dose Iodine-131–Metaiodobenzylguanidine Therapy for Advanced Neuroblastoma
2004
Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas
1998
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Terminology and morphologic criteria of neuroblastic tumors
1999
MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
2000
Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor Study
2001
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
2002
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
1999 Science
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
2000 StandoutScience
Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family
1991 StandoutNobel
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.
1995
Molecular Biology of Neuroblastoma
1999
Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study
2000
Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73
1998 StandoutNobel
Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor.
1986 StandoutNobel
DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.
1998
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
2001
Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia
2005
Evaluation of the Quality of Prognosis Studies in Systematic Reviews
2006
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model
1985 StandoutNatureNobel
Diagnosis of multiple cancer types by shrunken centroids of gene expression
2002 Standout
Pilot Study of Iodine-131–Metaiodobenzylguanidine in Combination With Myeloablative Chemotherapy and Autologous Stem-Cell Support for the Treatment of Neuroblastoma
2002
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Overexpression of c-Myc in β-Cells of Transgenic Mice Causes Proliferation and Apoptosis, Downregulation of Insulin Gene Expression, and Diabetes
2002
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
1997
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
2002
Second malignant neoplasms in children: an update from the Late Effects Study Group.
1985
The Measurement of Observer Agreement for Categorical Data
1977 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Another p53 Doppelgänger?
1998 StandoutScienceNobel
Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
1999
Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651
2003
Works of P.A. Voûte being referenced
First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma
1995
Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with Neuroblastoma
1996
The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis
2003
1p36: Every subband a suppressor?
1995
Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus
1996
Clustering of hypermethylated genes in neuroblastoma
2003
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.
1992
Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review
2002
Comparative genomic hybridization analysis of Wilms tumors
1997
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis
2001
Human megakaryocytes cultured in vitro accumulate serotonin but not meta-iodobenzylguanidine whereas platelets concentrate both
2002
Radionuclide therapy of neural crest tumors
1987
Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review
2002
Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis
1988
Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma
2002
Evidence for two tumour suppressor loci on chromosomal bands 1p35–36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification
1995
A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma
1999
Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
2002
Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin d, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the international society of paediatric oncology (S.I.O.P.)
1976
Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study
2001
Bilateral retinoblastoma with ectopic intracranial retinoblastoma: Trilateral retinoblastoma
1982
Cystathioninuria in patients with neuroblastoma
1984
Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors
1989
Leukemia After Therapy With Alkylating Agents for Childhood Cancer2
1987
Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group
2000
Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity.
1994
Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial.
1983
Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.
1987
Genes differentially expressed in medulloblastoma and fetal brain
1999
Role of metastatectomy without chemotherapy in the management of osteosarcoma in children
1980
Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86
2001
Excess of multifocal tumors in nephroblastoma: implications for mechanisms of tumor development and genetic counseling
1993